person

Carlos G.

Country
Belgium
Department
Hematologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
139
Sites with multiple studies

Has run more than one trial at 139 of 260 partner sites.

Specializations

Acute Leukemia Research

This investigator specializes in studying various forms of acute leukemia, with particular emphasis on both myeloid and lymphoblastic variants. Their research encompasses relapsed and refractory acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in adult patients.

  • IDH1 mutation-positive AML treatment approaches
  • RARA-positive leukemia interventions
  • NPM1-mutated AML therapies

The investigator's work includes innovative approaches such as dendritic cell vaccination and targeted molecular therapies.

Myelodysplastic Syndromes

A significant focus of research lies in treating higher-risk myelodysplastic syndrome (MDS), investigating novel therapeutic combinations and approaches for patient care.

  • RARA-positive MDS treatment strategies
  • Venetoclax combination therapies
  • Azacitidine-based treatment protocols

The research extends to studying treatment-naïve higher-risk MDS populations and novel therapeutic combinations.

Transplantation Medicine

The investigator conducts research in allogeneic hematopoietic stem cell transplantation, exploring various conditioning regimens and treatment protocols.

  • Reduced-intensity conditioning protocols
  • HLA-matched donor transplantation
  • Post-transplant therapeutic strategies

Their work encompasses transplantation approaches for various hematological malignancies, including both myeloid and lymphoid conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.